CANOPY GROWTH CORP (CGC) Stock Fundamental Analysis

NASDAQ:CGC • CA1380357048

1.08 USD
+0.05 (+4.85%)
At close: Feb 13, 2026
1.08 USD
0 (0%)
After Hours: 2/13/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall CGC gets a fundamental rating of 2 out of 10. We evaluated CGC against 191 industry peers in the Pharmaceuticals industry. The financial health of CGC is average, but there are quite some concerns on its profitability. CGC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CGC has reported negative net income.
  • In the past year CGC has reported a negative cash flow from operations.
  • CGC had negative earnings in each of the past 5 years.
  • In the past 5 years CGC always reported negative operating cash flow.
CGC Yearly Net Income VS EBIT VS OCF VS FCFCGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

  • The Return On Assets of CGC (-29.52%) is comparable to the rest of the industry.
  • CGC has a Return On Equity (-43.07%) which is in line with its industry peers.
Industry RankSector Rank
ROA -29.52%
ROE -43.07%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
CGC Yearly ROA, ROE, ROICCGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • CGC has a Gross Margin (26.56%) which is in line with its industry peers.
  • CGC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CGC Yearly Profit, Operating, Gross MarginsCGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • CGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CGC has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CGC has less shares outstanding
  • CGC has a better debt/assets ratio than last year.
CGC Yearly Shares OutstandingCGC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
CGC Yearly Total Debt VS Total AssetsCGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • CGC has an Altman-Z score of -9.07. This is a bad value and indicates that CGC is not financially healthy and even has some risk of bankruptcy.
  • CGC has a worse Altman-Z score (-9.07) than 67.54% of its industry peers.
  • CGC has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of CGC (0.32) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z -9.07
ROIC/WACCN/A
WACC11.83%
CGC Yearly LT Debt VS Equity VS FCFCGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 5.34 indicates that CGC has no problem at all paying its short term obligations.
  • CGC's Current ratio of 5.34 is fine compared to the rest of the industry. CGC outperforms 65.44% of its industry peers.
  • A Quick Ratio of 4.26 indicates that CGC has no problem at all paying its short term obligations.
  • CGC has a better Quick ratio (4.26) than 63.87% of its industry peers.
Industry RankSector Rank
Current Ratio 5.34
Quick Ratio 4.26
CGC Yearly Current Assets VS Current LiabilitesCGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 63.98% over the past year.
  • The Revenue has been growing slightly by 0.59% in the past year.
  • CGC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.57% yearly.
EPS 1Y (TTM)63.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.78%
Revenue 1Y (TTM)0.59%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-0.29%

3.2 Future

  • Based on estimates for the next years, CGC will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.29% on average per year.
  • The Revenue is expected to grow by 4.78% on average over the next years.
EPS Next Y94.65%
EPS Next 2Y40.65%
EPS Next 3Y25.38%
EPS Next 5Y15.29%
Revenue Next Year2.14%
Revenue Next 2Y4.71%
Revenue Next 3Y30.84%
Revenue Next 5Y4.78%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGC Yearly Revenue VS EstimatesCGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
CGC Yearly EPS VS EstimatesCGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CGC. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CGC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CGC Price Earnings VS Forward Price EarningsCGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGC Per share dataCGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CGC's earnings are expected to grow with 25.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.65%
EPS Next 3Y25.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CGC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CANOPY GROWTH CORP

NASDAQ:CGC (2/13/2026, 8:00:00 PM)

After market: 1.08 0 (0%)

1.08

+0.05 (+4.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-06
Earnings (Next)05-28
Inst Owners11.18%
Inst Owner Change36.75%
Ins Owners0.18%
Ins Owner Change4.4%
Market Cap436.36M
Revenue(TTM)278.39M
Net Income(TTM)-326.58M
Analysts47.69
Price Target2.49 (130.56%)
Short Float %10.37%
Short Ratio1.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-99.18%
Min EPS beat(2)-292.16%
Max EPS beat(2)93.8%
EPS beat(4)2
Avg EPS beat(4)-99.19%
Min EPS beat(4)-292.16%
Max EPS beat(4)93.8%
EPS beat(8)2
Avg EPS beat(8)-136.84%
EPS beat(12)3
Avg EPS beat(12)-180.14%
EPS beat(16)3
Avg EPS beat(16)-182.69%
Revenue beat(2)1
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-7.76%
Max Revenue beat(2)2.99%
Revenue beat(4)3
Avg Revenue beat(4)3.11%
Min Revenue beat(4)-7.76%
Max Revenue beat(4)9.57%
Revenue beat(8)5
Avg Revenue beat(8)2.85%
Revenue beat(12)7
Avg Revenue beat(12)2.61%
Revenue beat(16)8
Avg Revenue beat(16)-0.76%
PT rev (1m)-11.63%
PT rev (3m)-7.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)70.7%
EPS NY rev (1m)-4.09%
EPS NY rev (3m)53.1%
Revenue NQ rev (1m)1.95%
Revenue NQ rev (3m)-5.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.14
P/FCF N/A
P/OCF N/A
P/B 0.78
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)-1.38
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.51
BVpS1.38
TBVpS1.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -29.52%
ROE -43.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.56%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.34%
Cap/Sales 2.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.34
Quick Ratio 4.26
Altman-Z -9.07
F-Score5
WACC11.83%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.78%
EPS Next Y94.65%
EPS Next 2Y40.65%
EPS Next 3Y25.38%
EPS Next 5Y15.29%
Revenue 1Y (TTM)0.59%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-0.29%
Revenue Next Year2.14%
Revenue Next 2Y4.71%
Revenue Next 3Y30.84%
Revenue Next 5Y4.78%
EBIT growth 1Y56.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.39%
EBIT Next 3Y31%
EBIT Next 5Y18.13%
FCF growth 1Y78.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.31%
OCF growth 3YN/A
OCF growth 5YN/A

CANOPY GROWTH CORP / CGC FAQ

Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?

ChartMill assigns a fundamental rating of 2 / 10 to CGC.


What is the valuation status of CANOPY GROWTH CORP (CGC) stock?

ChartMill assigns a valuation rating of 1 / 10 to CANOPY GROWTH CORP (CGC). This can be considered as Overvalued.


What is the profitability of CGC stock?

CANOPY GROWTH CORP (CGC) has a profitability rating of 1 / 10.


What is the financial health of CANOPY GROWTH CORP (CGC) stock?

The financial health rating of CANOPY GROWTH CORP (CGC) is 4 / 10.